Skip to main content
TipRanks
Go Ultimate75% OFF

PharmaCielo (PCLO) Financial Statements

53 Followers

PharmaCielo Financial Overview

PharmaCielo's market cap is currently C$8.41M. The company's EPS TTM is C$-0.02; its P/E ratio is -2.41; PharmaCielo has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Jun 24Mar 23Mar 22
Income Statement
Total RevenueC$ 2.61MC$ 3.48MC$ 1.54MC$ 5.31MC$ 1.94M
Gross ProfitC$ 756.40KC$ 730.88KC$ -1.37MC$ 827.06KC$ -4.31M
Operating IncomeC$ -3.82MC$ -4.90MC$ -9.70MC$ -11.46MC$ -25.46M
EBITDAC$ -1.00MC$ -4.60MC$ -12.19MC$ -10.50MC$ -24.34M
Net IncomeC$ -4.55MC$ -9.14MC$ -16.30MC$ -16.04MC$ -26.92M
Balance Sheet
Cash & Short-Term InvestmentsC$ 289.24KC$ 147.94KC$ 62.18KC$ 325.98KC$ 5.63M
Total AssetsC$ 8.56MC$ 18.39MC$ 22.29MC$ 25.12MC$ 35.96M
Total DebtC$ 18.65MC$ 20.52MC$ 18.31MC$ 12.59MC$ 8.43M
Net DebtC$ 18.36MC$ 20.38MC$ 18.25MC$ 12.41MC$ 3.09M
Total LiabilitiesC$ 23.92MC$ 25.91MC$ 23.97MC$ 18.72MC$ 16.63M
Stockholders' EquityC$ -15.35MC$ -7.52MC$ -1.68MC$ 6.39MC$ 19.33M
Cash Flow
Free Cash FlowC$ -1.02MC$ -1.97MC$ -5.17MC$ -10.23MC$ -21.21M
Operating Cash FlowC$ -1.02MC$ -1.97MC$ -5.15MC$ -9.71MC$ -20.07M
Investing Cash FlowC$ 6.66MC$ 41.14KC$ 391.64KC$ -725.49KC$ -1.66M
Financing Cash FlowC$ -5.52MC$ 2.02MC$ 4.63MC$ 5.30MC$ 18.21M

Currency in CAD

PharmaCielo Earnings and Revenue History

-50M-25M025M-6000 %-4000 %-2000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

PharmaCielo Liabilities to Assets

020M40M60M0 %100 %200 %300 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

PharmaCielo Cash Flow

-30M-20M-10M010M20M30M201720182019202020212022202320242025OperatingInvestingFinancing

PharmaCielo Forecast EPS vs Actual EPS

0000000Q2 25Q3 25Q4 25Q1 26Q4 26Q1 26EPS EstimateBeatMiss